| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Sailer Carl serves as a Director at ACXP. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $202K at current prices.
Historically, Sailer Carl's trades have earned a below-average insider score of 19/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -54.5%.
The biggest single holding is ACXP (~$202K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 62,029 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | ACXP Acurx Pharmaceuticals, Inc. | Director | Buy | 24,631 | $1.02 | $25,000.46 | +21.9% | -69.9% | -86.6% | |
| Jul 27, 2022 | ACXP Acurx Pharmaceuticals, Inc. | Director | Buy | 19,737 | $3.80 | $75,000.60 | +27.0% | -13.2% | -52.4% | |
| Nov 23, 2021 | ACXP Acurx Pharmaceuticals, Inc. | Director | Buy | 5,161 | $4.84 | $24,979.24 | +7.6% | -14.2% | -37.1% | |
| Jun 29, 2021 | ACXP Acurx Pharmaceuticals, Inc. | Director | Buy | 12,500 | $6.00 | $75,000.00 | +22.6% | -28.9% | -42.0% |